In contrast, Leiva et al. [45] explored outcomes in 136 patients with von Willebrand disease (VWD) following AMI and reported a higher rate of bleeding-related readmissions but no significant increase in arterial thrombosis, suggesting that VWD may confer a protective effect against thrombotic complications. The gene discussed is VWF; the disease is von Willebrand disease (hereditary or acquired).